Talphera, Inc.

US$1.05As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TLPHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (32.76%)
Div yield —
ROE (143.36%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.73
PE TTM —
TSR TTM (21.64%)
Mkt cap US$54.50M
ROIC (383.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.21
15.52%
(70.13%)
Hold 2|5|1|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
3.63%
1.72%
5.75%
(1.63%)
Revenue$M
4.529
4.516
4.411
4.653
6.98%
5.51%
5.22%
7.75%
Peers (US$54.50M)
Cap (US$)
PE
34.82M
—
Capital
TTM
5Y
10Y
Leveragex
0.491
0.080
0.059
EBIT/Intx
2.467
0.176
0.187
Own earn%
(55.76)
46.02
25.47
Sh yield%
45.24
47.37
46.12
Owners
Insiders/Inst%
0.34
84.77
Short interest%
2.55
SBC / revenue%
5.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
7–10
$1 testx
—
Incr. ROIC%
47